about
Performance Evaluation of Allplex Respiratory Panels 1, 2, and 3 for Detection of Respiratory Viruses and Influenza A Virus SubtypesFirst case of nontuberculous mycobacterial lung disease caused by Mycobacterium marseillense in a patient with systemic lupus erythematosus.Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients.Performance evaluation of the Xpert MTB/RIF assay according to its clinical application.Evaluation of performance of the Real-Q NTM-ID kit for rapid identification of eight nontuberculous mycobacterial species.Species-specific difference in antimicrobial susceptibility among viridans group streptococci.Molecular analysis of clinical isolates previously diagnosed as Mycobacterium intracellulare reveals incidental findings of "Mycobacterium indicus pranii" genotypes in human lung infection.Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung DiseaseLaboratory Identification of Leptotrichia Species Isolated From Bacteremia Patients at a Single Institution.Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens.Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary TuberculosisblaNDM-5-Bearing IncFII-Type Plasmids of Klebsiella pneumoniae Sequence Type 147 Transmitted by Cross-Border Transfer of a Patient.Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience.Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosisClinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung DiseaseAnalysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus.Performance of the Real-Q EBV Quantification Kit for Epstein-Barr Virus DNA Quantification in Whole Blood.The First Korean Case of Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium abscessus Subspecies bolletii in a Patient with Bronchiectasis.Distribution of nontuberculous mycobacteria by multigene sequence-based typing and clinical significance of isolated strains.Low virulence? Clinical characteristics of Raoultella planticola bacteremia.Clinical characteristics of Raoultella ornithinolytica bacteremia.Clinical characteristics and treatment outcomes of pulmonary disease caused by Mycobacterium chimaera.Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-resistant Mycobacterium abscessus Lung Disease.Invasive Fungal Sinusitis by Lasiodiplodia theobromae in an Patient with Aplastic Anemia: An Extremely Rare Case Report and Literature Review.Comparison of the genedia MTB detection kit and the cobas TaqMan MTB assay for detection of Mycobacterium tuberculosis in respiratory specimens.MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study.Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene.Performance Evaluation of the PowerChek MERS (upE & ORF1a) Real-Time PCR Kit for the Detection of Middle East Respiratory Syndrome Coronavirus RNA.Development of a One-Step Multiplex PCR Assay for Differential Detection of Major Mycobacterium Species.Atypical presentations of MERS-CoV infection in immunocompromised hosts.Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.Identification of mucorales from clinical specimens: a 4-year experience in a single institutionMycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.Comparative evaluation of the AdvanSure Mycobacteria GenoBlot assay and the GenoType Mycobacterium CM/AS assay for the identification of non-tuberculous mycobacteria.A case of Bacteroides pyogenes bacteremia secondary to liver abscess.Analytical and clinical evaluation of the Abbott RealTime hepatitis B sequencing assay.Performance Evaluation of the Real-Q Cytomegalovirus (CMV) Quantification Kit Using Two Real-Time PCR Systems for Quantifying CMV DNA in Whole BloodControl of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea.Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease.
P50
Q30395828-6284EC14-4610-468F-940C-0CD800DEADBFQ30809495-BE11A2DC-53E4-44F0-AA6D-FF63392858F8Q33434536-88E6E5F3-378A-4FE0-A49F-4E28B0739BCDQ34584703-0D07EBAB-D649-4643-B3A3-08EE9D87E9C8Q35036138-016720D7-D823-445F-A721-712F4E4C46CBQ35088472-FA2466F1-24B3-49CA-A31F-83A063310890Q35793970-32896927-E440-497D-8AEE-48CD063A7A91Q35797447-6E1ED62E-022F-49FE-94EE-14A094D9418FQ35859886-C898ED4F-DEA0-41BA-8312-020907C8DB3DQ36287174-090AEC10-9C4B-4701-8B6E-FB0CBC182C07Q36307321-B5943008-B3C3-49F8-8860-7857ED636CC2Q36439006-275413A2-05DA-4F72-BB1A-053B189F7C63Q36644670-E475CC70-60AA-472E-ADC4-0250926CD014Q36660513-6B126E0C-5AA6-40CA-A825-DB41B8E19197Q37165276-37888425-516F-4B18-8FAB-9D007CC1F534Q37358685-01262F46-A36D-4FEC-B0FF-BF5C09673995Q37416692-8D9451B1-92A4-48FE-ABB3-D74D673E8417Q37547785-124B013A-AA28-4B83-9ABF-700A82548CF6Q37575194-6DFB7A83-AE3A-44FA-8128-BDE68F9B3D46Q37713488-8562889B-FB55-490A-96ED-7E313E164340Q38232277-CD095FCD-5B00-4E3D-AE8C-BBED91E90FC6Q38264795-C278D810-EA0C-4F59-ABFA-9681CD4EC1C1Q38408970-ECC90680-2126-4E0A-A480-553980ED277BQ38663720-B520FCE8-5FCB-495C-A62D-D4C873D7BD75Q38959911-538BF11B-5B93-4318-89B4-029EC05DDB7FQ39420244-6B2559BD-D27C-40F8-9C44-F972271F6C12Q39611910-2513A499-0893-4D90-9F80-F6CF56FA5C72Q40053136-41ECCBAB-3358-476C-B32C-ED1015E2B915Q40070511-3E55751F-63E7-4EA6-B270-2BD896A3C6FCQ40154522-12CA3861-3C92-4EC6-A35B-EB466C7B6A77Q40184785-E99FD15B-75B6-48D8-91EA-BE54319DA08FQ40206926-1D9574EF-59F9-4D5F-A664-FEA6B4FFA7BCQ40368876-C6D58DA1-2E06-4752-AAFF-35D9C8EE5162Q40397189-20D2FE3B-FE74-45A5-B0D1-0225991795BAQ40429823-24372093-5663-4BB5-8E5C-626066103B63Q40466925-CD3E3B59-8E35-4506-8A9A-E2800DD4812EQ40488309-ED024370-32E2-4FE9-892D-9590D556ED5FQ40557237-20E10266-BE63-4B66-A7A9-3C553E55ED58Q40641880-A3564E6F-BE04-44E3-9527-8152A95F9051Q40679353-53DBAAC7-4782-40D5-BCB9-BB7E1B7F7B78
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hee Jae Huh
@ast
Hee Jae Huh
@en
Hee Jae Huh
@es
Hee Jae Huh
@nl
Hee Jae Huh
@sl
type
label
Hee Jae Huh
@ast
Hee Jae Huh
@en
Hee Jae Huh
@es
Hee Jae Huh
@nl
Hee Jae Huh
@sl
prefLabel
Hee Jae Huh
@ast
Hee Jae Huh
@en
Hee Jae Huh
@es
Hee Jae Huh
@nl
Hee Jae Huh
@sl
P106
P31
P496
0000-0001-8999-7561
P5008
P569
2000-01-01T00:00:00Z